References
- Huchcroft S, Gunton P, Bowen T. Compliance with postpartum Rh isoimmunization prophylaxis in Alberta. Can Med Assoc J 1985;133:871–5.
- Lloyd Jones M, Wray J, Wight, J, et al. A review of the clinical effectiveness of routine antenatal anti-D prophylaxis for rhesus-negative women who are pregnant. Br J Obstet Gynaecol 2004;111:892–902.
- Bowman JM, Chown B, Lewis M, et al. Rh isoimmunization during pregnancy: antenatal prophylaxis. Can Med Assoc J 1978;118:623–7.
- Bowman JM, Pollock JM. Antenatal prophylaxis of Rh isoimmunization: 28 weeks’-gestation service program. Can Med Assoc J 1978;118,:627–30.
- De Silva M, Engelfriet CP, Reesink HW. International Forum: current status of immunoprophylaxis with anti-D immunoglobulin. Vox Sang 2003;85:328–37.
- Bowman JM, Chown B, Lewis M, et al. Rh isoimmunization, Manitoba, 1963–1975. Can Med Assoc J 1977;116:282–4.
- Tuohy JF, Sangalli M, Kim L. Red blood cell iso-immunization in the Wellington area of New Zealand: the case for antenatal prophylaxis. Aust NZ J Obstet Gynaecol 2004;44:458–9.
- Hughes RG, Craig JIO, Murphy WG, et al. Causes and clinical consequences of Rhesus (D) haemolytic disease of the newborn: a study of the Scottish population, 1985–1990. Br J Obstet Gynaecol 1994;101:297–300.
- McSweeney E, Kirkham J, Vinall P, et al. An audit of anti-D sensitization in Yorkshire. Br J Obstet Gynaecol 1998;105: 1091–4.
- http://www.shotuk.org/reporting/anti-d-immunisation-reporting/. Accessed August 11, 2016.